A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

Tennessee's Medicaid program, TennCare, covers drugs like Ozempic and Mounjaro to treat those with diabetes and heart ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...

Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...

Join the debate on weight loss drugs at NAILBA 43. Experts discuss the risk factors and effectiveness of GLP-1 drugs like Ozempic.

Aloe vera is a natural supplement that has been shown to lower blood glucose levels and improve cholesterol profiles. Aloe ...

The Ipsos survey of 1,078 adults found 24% of people would use weight-loss jabs if they were provided for free by the health ...

It sounds great, considering the cost of brand-name drugs ... There are four FDA-approved GLP-1 drugs you’ve likely heard of: ...

The survey of 1,078 adults, carried out by Ipsos, found 24% of people would use weight-loss jabs if they were provided for ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.